QTX3034

· Quanta Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QTX3034, covering 2025-12-24 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: QTX3034 in Patients With KRAS G12D Mutation [Phase 1]